| Literature DB >> 34956841 |
Noemi Anja Brog1, Julia Katharina Hegy1, Thomas Berger2, Hansjörg Znoj1.
Abstract
BACKGROUND: The COVID-19 pandemic and its far-reaching impact on physical and mental health generate high demand and, accordingly, a great need for treatment opportunities that promote well-being and manage psychological distress. Internet-based interventions are particularly suitable for this purpose. They are easily scalable, readily accessible, and the online format allows for adherence to social distancing. For this reason, we developed an internet-based self-help intervention called ROCO to address psychological distress due to the COVID-19 pandemic. This randomized controlled trial aimed to examine the efficacy of the ROCO intervention.Entities:
Keywords: COVID-19; Coronavirus; Depression; Internet-based self-help; Psychological distress
Year: 2021 PMID: 34956841 PMCID: PMC8684052 DOI: 10.1016/j.invent.2021.100492
Source DB: PubMed Journal: Internet Interv ISSN: 2214-7829
Fig. 1Selection, randomization, and flow of participants throughout the trial.
Outline of the content of the internet-based self-help intervention ROCO.
| Introduction | Information on the self-help intervention and its handling |
| 1. Identifying consequences and challenges | Psychoeducation on COVID-19 related psychological distress, evaluation of the current well-being (bodily sensations, positive, and negative feelings), resource-oriented weekly task |
| 2. Understanding own feelings | Psychoeducation on emotions such as anxiety, helplessness, anger, sense of shame, and sadness, emotion regulation skills, acceptance-oriented weekly task |
| 3. Changing the perspective | Psychoeducation on the influence of thoughts, automatic thoughts, rumination, and irrational beliefs, restructuring thought patterns, weekly task on rumination |
| 4. Strengthening resilience | Psychoeducation on resilience, promoting coping, joie de vivre, and optimism, resource-oriented weekly task |
| 5. Finding rest | Psychoeducation on sleep, sleep hygiene, and relaxation techniques, progressive muscle relaxation as weekly task |
| 6. Taking care of oneself | Psychoeducation on the concept of post-traumatic growth and the importance of indulgence, gratitude and mindfulness exercises, resource-based weekly task |
| Conclusion | Information on maintaining and transferring what has been learned into everyday life |
Demographics and sample characteristics at baseline for the treatment and waiting control group.
| Total | Treatment group | Control group | Statistic | |
|---|---|---|---|---|
| Age, | 40.36(14.59) | 40.68 (15.55) | 40.04 (13.73) | t( |
| Gender, | ||||
| Male | 19 (17.8) | 7 (13.2) | 12 (22.2) | |
| Female | 87 (81.3) | 46 (86.8) | 41 (75.9) | |
| Non-binary | 1 (0.9) | – | 1 (1.9) | |
| Current marital status, | ||||
| Single | 65 (60.7) | 36 (67.9) | 29 (53.7) | |
| Married/Civil Union | 30 (28.0) | 15 (28.3) | 15 (27.8) | |
| Divorced/Civil Union annulled | 11 (1.3) | 2 (3.8) | 9 (16.7) | |
| Widowed/Civil partner died | 1 (0.9) | – | 1 (1.9) | |
| Education, | ||||
| Compulsory School | 3 (2.8) | 2 (3.8) | 1 (1.9) | |
| Apprenticeship | 21 (19.6) | 16 (30.2) | 5 (9.3) | |
| Secondary II | 19 (17.8) | 9 (17.0) | 10 (18.6) | |
| University | 64 (59.8) | 26 (49.0) | 38 (70.4) | |
| Employment, | ||||
| Full-time paid work | 27 (25.2) | 14 (26.4) | 13 (24.1) | |
| Part-time paid work | 51 (47.5) | 24 (45.3) | 27 (50.0) | |
| Unemployed | 3 (2.8) | 2 (3.8) | 1 (1.9) | |
| At-home parent | 4 (3.7) | 3 (5.7) | 1 (1.9) | |
| Student | 13 (12.1) | 5 (9.4) | 8 (14.8) | |
| Retired | 9 (8.4) | 5 (9.4) | 4 (7.4) | |
| Nationality, | ||||
| Swiss | 78 (72.9) | 36 (67.9) | 42 (77.8) | |
| German Speaking countries | 26 (24.3) | 14 (26.5) | 12 (22.3) | |
| Other Countries | 3 (2.7) | 3 (5.7) | – | |
| Psychological Treatment, | ||||
| Past | 68 (63.6) | 38 (71.7) | 30 (55.6) | |
| Current | 28 (26.2) | 14 (26.4) | 14 (25.9) | |
| Current Medications, | 24 (22.4) | 14 (26.4%) | 10 (18.5) | |
| Depressive symptoms | ||||
| Gesamtwert, | 11.07 (4.23) | 11.13 (4.36) | 11.00 (4.14) | |
| Mild, | 41 (38.3) | 21 (39.6) | 20 (37.0) | |
| Moderate, | 42 (39.3) | 18 (34.0) | 24 (44.4) | |
| Severe, | 24 (22.4) | 14 (6.4) | 10 (18.5) |
Chi-Square calculations include only categories with a frequency > 3.
Bootstrap 1000 samples.
Observed and estimated means for primary and secondary outcome measures and within- and between-group effect sizes.
| Outcome | Pre-treatment | Post-treatment (observed) | Post-treatment (estimated) | Follow up (observed) | Post-treatment between group comparisons | Pre-Post within group effect sizes (estimated means) | Between-group effect sizes at post-treatment (estimated means) | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| PHQ-9 | |||||||||||
| Intervention | 11.13 (4.36) | 53 | 9.56 (3.70) | 45 | 9.63 (0.59) | 53 | 8.75 (5.07) | 36 | 0.37 (−0.18–0.91) | 0.04 | |
| Control | 11.00 (4.14) | 54 | 9.60 (3.89) | 52 | 9.67 (0.56) | 54 | 0.33 (−0.21–0.87) | ||||
| DASS-21 | |||||||||||
| Intervention | 21.53 (9.23) | 53 | 20.27 (10.84) | 45 | 20.66 (1.39) | 53 | 17 (10.44) | 36 | 0.09 (−0.45–0.63) | −0.19 | |
| Control | 22.37 (9.86) | 54 | 19.33 (9.13) | 52 | 19.66 (1.34) | 54 | 0.29 (−0.25–0.82) | ||||
| SF-12 MH | |||||||||||
| Intervention | 31.10 (9.10) | 53 | 36.72 (11.01) | 43 | 36.47 (1.35) | 53 | 38.31 (10.40) | 36 | 0.54 (−0.01–1.09) | 0.24 | |
| Control | 28.81 (7.73) | 54 | 32.23 (9.20) | 52 | 32.14 (1.27) | 54 | 0.39 (−0.15–0.93) | ||||
| SF-12 PH | |||||||||||
| Intervention | 53.43 (8.79) | 53 | 50.96 (10.03) | 43 | 51.26 (1.16) | 53 | 51.26 (11.24) | 36 | −0.23 (−0.77–0.31) | 0.01 | |
| Control | 56.11 (6.98) | 54 | 53.87 (6.43) | 52 | 53.86 (1.10) | 54 | −0.34 (−0.87–0.20) | ||||
| LOT-R O | |||||||||||
| Intervention | 7.19 (2.73) | 53 | 7.52 (2.62) | 42 | 7.45 (0.38) | 53 | 7.69 (2.86) | 36 | 0.10 (−0.44–0.64) | 0.12 | |
| Control | 6.87 (2.33) | 54 | 6.84 (2.65) | 50 | 6.82 (0.36) | 54 | −0.02 (−0.55–0.51) | ||||
| LOT-R P | |||||||||||
| Intervention | 4.75 (2.76) | 53 | 4.67 (2.39) | 42 | 4.63 (0.39) | 53 | 4.58 (2.31) | 36 | 0.05 (−0.49–0.59) | −0.02 | |
| Control | 4.70 (2.63) | 54 | 4.62 (2.91) | 50 | 4.64 (0.37) | 54 | 0.02 (−0.51–0.56) | ||||
| BEI | |||||||||||
| Intervention | 8.75 (4.88) | 53 | 8.45 (4.23) | 42 | 8.52 (0.71) | 53 | 7.61 (4.69) | 36 | 0.05 (−0.49–0.59) | 0.04 | |
| Control | 10.07 (4.96) | 54 | 9.50 (5.22) | 50 | 9.62 (0.68) | 54 | 0.09 (−0.45–0.62) | ||||
| ULS | |||||||||||
| Intervention | 21.26 (4.82) | 53 | 19.88 (4.56) | 43 | 20.12 (0.64) | 53 | 19.28 (4.94) | 36 | 0.24 (−0.30–0.78) | 0.20 | |
| Control | 20.37 (4.25) | 54 | 20.27 (4.04) | 52 | 20.16 (0.61) | 54 | 0.05 (−0.48–0.58) | ||||
| GSE | |||||||||||
| Intervention | 25.91 (4.47) | 53 | 26.88 (4.81) | 43 | 26.88 (0.66) | 53 | 27.03 (5.35) | 36 | 0.21 (−0.33–0.75) | 0.17 | |
| Control | 26.56 (4.72) | 54 | 26.69 (4.47) | 51 | 26.74 (0.63) | 54 | 0.04 (−0.49–0.57) | ||||
| SEK-27 | |||||||||||
| Intervention | 62.64 (15.45) | 53 | 73.33 (15.19) | 42 | 71.68 (2.33) | 53 | 73.92 (17.57) | 36 | 0.59 (0.04–1.14) | 0.35 | |
| Control | 59.83 (16.61) | 54 | 62.76 (16.65) | 50 | 63.17 (2.22) | 54 | 0.20 (−0.33–0.74) | ||||
| CD-RISC | |||||||||||
| Intervention | 21.87 (6.62) | 53 | 23.48 (6.43) | 42 | 23.47 (0.92) | 53 | 23.11 (6.51) | 36 | F( | 0.25 (−0.30–0.79) | 0.38 |
| Control | 23.78 (5.47) | 54 | 23.10 (6.75) | 50 | 23.05 (0.88) | 54 | −0.12 (−0.65–0.42) | ||||
| SBQ-R | |||||||||||
| Intervention | 4.92 (1.36) | 53 | 5.18 (1.78) | 45 | 5.15 (0.21) | 53 | 5.36 (1.79) | 36 | −0.15 (−0.69–0.39) | −0.02 | |
| Control | 4.72 (1.28) | 54 | 4.92 (1.41) | 52 | 4.93 (0.20) | 54 | −0.16 (−0.69–0.38) |
M, mean; SD, standard deviation; SE, standard error; df, degrees of freedom; CI, confidence interval; PHQ-9, Patient Health Questionnaire; DASS-21, Depression Anxiety Stress Scale; SF-12 MH, Short-Form Health Survey mental health subscale, SF-12 PH, Short-Form Health Survey physical health subscale; LOT-R O, Life Orientation Test Revised optimism subscale; LOT-R P, Life Orientation Test Revised pessimism subscale; BEI, Bern Embitterment Inventory; ULS, UCLA Loneliness Scale; GSE, General Self-Efficacy Scale; SEK-27, Self-report Measure to measure emotion regulation skills; CD-RISC, Connor-Davidson Resilience Scale; SBQ-R, Suicide Behavior Questionnaire Revised.
Intention-to-treat analysis.
Observed and estimated means for the DASS-21 and within- and between-group effect sizes, considering concurrent psychological treatment and medication intake.
| Outcome | Pre-treatment | Post-treatment (observed) | Post-treatment (estimated) | Post-treatment between group comparisons | Pre-Post within group effect sizes (estimated means) | Between-group effect sizes at post-treatment (estimated means) | |||
|---|---|---|---|---|---|---|---|---|---|
| DASS-21 | |||||||||
| Concurrent psychological treatment | |||||||||
| Intervention | 22.86 (8.51) | 14 | 25.00 (10.58) | 12 | 25.77 (2.69) | 14 | −0.31 (−1.36–0.75) | −0.73 | |
| Control | 21.07 (9.68) | 14 | 16.54 (8.59) | 13 | 17.17 (2.64) | 14 | 0.43 (−0.63–1.49) | ||
| No concurrent psychological treatment | |||||||||
| Intervention | 21.05 (9.53) | 39 | 18.66 (10.56) | 33 | 18.81 (1.62) | 39 | 0.22 (−0.41–0.85) | 0.01 | |
| Control | 22.83 (10.00) | 40 | 20.26 (9.22) | 39 | 20.51 (1.54) | 40 | 0.24 (−0.38–0.86) | ||
| DASS-21 | |||||||||
| Concurrent medication intake | |||||||||
| Intervention | 25.29 (7.62) | 14 | 27.91 (12.01) | 11 | 27.53 (2.63) | 14 | −0.23 (−1.28–0.82) | −0.85 | |
| Control | 31.20 (9.86) | 10 | 25.90 (11.61) | 10 | 25.90 (2.93) | 10 | 0.49 (−0.77–1.75) | ||
| No concurrent medication intake | |||||||||
| Intervention | 20.18 (9.59) | 38 | 17.82 (9.48) | 33 | 18.37 (1.56) | 38 | 0.19 (−0.45–0.83) | 0.05 | |
| Control | 20.51 (8.83) | 43 | 17.93 (7.83) | 41 | 18.40 (1.43) | 43 | 0.25 (−0.35–0.85) |
M, mean; SD, standard deviation; SE, standard error; df, degrees of freedom; CI, confidence interval; DASS-21, Depression Anxiety Stress Scale.
Intention-to-treat analysis.